Velsera
A Scientific Lead at Velsera leverages advanced molecular biology and cancer biology expertise to shape the company’s clinical genomics knowledgebase and support clinical NGS reporting. The role contributes to translating scientific evidence into structured knowledge to accelerate discovery and delivery of life-changing insights and is based in Pune (hybrid).
Headquarters
Charlestown, Massachusetts, United States
Company Size
501-1000 employees
Founded
2023
Velsera accelerates precision medicine development and delivery with AI-enhanced software and expert services for multimodal data analysis, IVD validation, clinical NGS reporting, and drug discovery workflows.
New Company, Velsera, Represents Summa Equity's Vision to Improve Global Health Outcomes
Jan 23, 2023
Illumina announces expansion of TruSight Oncology portfolio
Nov 19, 2024
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Mar 5, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Velsera.
Velsera didn’t post a salary, so this is our estimate from similar listings.
Medtech startup, spun out of WashU, acquired in deal that creates new company
Jan 13, 2023
Research Scientist - Molecular Medicine & Therapeutics
The Ohio State University
Scientific Support Manager
Watchmaker Genomics
Assistant Professor of Molecular Biology, Genomics, or Bioinformatics
Louisiana State University
Director, Clinical Genomics & Molecular Assay Development
Bristol Myers Squibb
Postdoctoral Research Associate in Crop Genetics and Functional Genomics
Iowa State University
Founding Scientist / Co-Founder
Clera